nodes	percent_of_prediction	percent_of_DWPC	metapath
Methimazole—CYP2A6—Nevirapine—acquired immunodeficiency syndrome	0.0464	0.0561	CbGbCtD
Methimazole—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.0321	0.0389	CbGbCtD
Methimazole—CYP2A6—Zidovudine—acquired immunodeficiency syndrome	0.0305	0.0369	CbGbCtD
Methimazole—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.0302	0.0366	CbGbCtD
Methimazole—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.0302	0.0366	CbGbCtD
Methimazole—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.0273	0.0331	CbGbCtD
Methimazole—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.0229	0.0277	CbGbCtD
Methimazole—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.021	0.0254	CbGbCtD
Methimazole—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.0207	0.0251	CbGbCtD
Methimazole—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0204	0.0247	CbGbCtD
Methimazole—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0192	0.0232	CbGbCtD
Methimazole—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0188	0.0228	CbGbCtD
Methimazole—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0177	0.0214	CbGbCtD
Methimazole—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0177	0.0214	CbGbCtD
Methimazole—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0174	0.021	CbGbCtD
Methimazole—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0174	0.021	CbGbCtD
Methimazole—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.017	0.0205	CbGbCtD
Methimazole—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.016	0.0194	CbGbCtD
Methimazole—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.016	0.0193	CbGbCtD
Methimazole—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.016	0.0193	CbGbCtD
Methimazole—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0155	0.0188	CbGbCtD
Methimazole—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.015	0.0181	CbGbCtD
Methimazole—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0146	0.0177	CbGbCtD
Methimazole—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0146	0.0177	CbGbCtD
Methimazole—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0145	0.0176	CbGbCtD
Methimazole—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0144	0.0175	CbGbCtD
Methimazole—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0144	0.0175	CbGbCtD
Methimazole—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0134	0.0162	CbGbCtD
Methimazole—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0132	0.016	CbGbCtD
Methimazole—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0132	0.016	CbGbCtD
Methimazole—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0132	0.0159	CbGbCtD
Methimazole—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0132	0.0159	CbGbCtD
Methimazole—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0126	0.0153	CbGbCtD
Methimazole—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0125	0.0151	CbGbCtD
Methimazole—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0121	0.0147	CbGbCtD
Methimazole—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0121	0.0146	CbGbCtD
Methimazole—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0114	0.0138	CbGbCtD
Methimazole—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0111	0.0134	CbGbCtD
Methimazole—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0109	0.0132	CbGbCtD
Methimazole—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0109	0.0132	CbGbCtD
Methimazole—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0105	0.0127	CbGbCtD
Methimazole—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.01	0.0121	CbGbCtD
Methimazole—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.01	0.0121	CbGbCtD
Methimazole—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00987	0.0119	CbGbCtD
Methimazole—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00928	0.0112	CbGbCtD
Methimazole—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00928	0.0112	CbGbCtD
Methimazole—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00839	0.0102	CbGbCtD
Methimazole—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00839	0.0102	CbGbCtD
Methimazole—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00725	0.00876	CbGbCtD
Methimazole—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00703	0.00851	CbGbCtD
Methimazole—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00636	0.0077	CbGbCtD
Methimazole—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00636	0.0077	CbGbCtD
Methimazole—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0061	0.00738	CbGbCtD
Methimazole—TPO—lymphoid tissue—acquired immunodeficiency syndrome	0.00212	0.0897	CbGeAlD
Methimazole—TPO—digestive system—acquired immunodeficiency syndrome	0.00209	0.0886	CbGeAlD
Methimazole—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00127	0.0539	CbGeAlD
Methimazole—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00104	0.044	CbGeAlD
Methimazole—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.000995	0.0422	CbGeAlD
Methimazole—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000985	0.0418	CbGeAlD
Methimazole—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.000934	0.0396	CbGeAlD
Methimazole—Jaundice—Nelfinavir—acquired immunodeficiency syndrome	0.000841	0.00561	CcSEcCtD
Methimazole—Jaundice—Stavudine—acquired immunodeficiency syndrome	0.000838	0.0056	CcSEcCtD
Methimazole—Agranulocytosis—Nevirapine—acquired immunodeficiency syndrome	0.000831	0.00555	CcSEcCtD
Methimazole—Neuropathy peripheral—Abacavir—acquired immunodeficiency syndrome	0.00083	0.00554	CcSEcCtD
Methimazole—Lymphadenopathy—Lamivudine—acquired immunodeficiency syndrome	0.000812	0.00542	CcSEcCtD
Methimazole—Hepatitis—Nevirapine—acquired immunodeficiency syndrome	0.0008	0.00534	CcSEcCtD
Methimazole—Alopecia—Didanosine—acquired immunodeficiency syndrome	0.000786	0.00525	CcSEcCtD
Methimazole—Hepatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000774	0.00517	CcSEcCtD
Methimazole—Hepatitis—Stavudine—acquired immunodeficiency syndrome	0.000772	0.00515	CcSEcCtD
Methimazole—Hepatitis—Abacavir—acquired immunodeficiency syndrome	0.000761	0.00508	CcSEcCtD
Methimazole—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000751	0.0318	CbGeAlD
Methimazole—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000739	0.0313	CbGeAlD
Methimazole—Neuropathy peripheral—Zidovudine—acquired immunodeficiency syndrome	0.000733	0.00489	CcSEcCtD
Methimazole—Jaundice—Zidovudine—acquired immunodeficiency syndrome	0.000729	0.00486	CcSEcCtD
Methimazole—Myalgia—Amprenavir—acquired immunodeficiency syndrome	0.000723	0.00483	CcSEcCtD
Methimazole—Agranulocytosis—Zidovudine—acquired immunodeficiency syndrome	0.000698	0.00466	CcSEcCtD
Methimazole—Leukopenia—Didanosine—acquired immunodeficiency syndrome	0.000693	0.00463	CcSEcCtD
Methimazole—Neuropathy peripheral—Indinavir—acquired immunodeficiency syndrome	0.000681	0.00455	CcSEcCtD
Methimazole—Jaundice—Indinavir—acquired immunodeficiency syndrome	0.000678	0.00452	CcSEcCtD
Methimazole—Alopecia—Abacavir—acquired immunodeficiency syndrome	0.000672	0.00449	CcSEcCtD
Methimazole—Hepatitis—Zidovudine—acquired immunodeficiency syndrome	0.000671	0.00448	CcSEcCtD
Methimazole—CYP2A6—vagina—acquired immunodeficiency syndrome	0.000671	0.0284	CbGeAlD
Methimazole—Myalgia—Didanosine—acquired immunodeficiency syndrome	0.000659	0.0044	CcSEcCtD
Methimazole—Arthralgia—Didanosine—acquired immunodeficiency syndrome	0.000659	0.0044	CcSEcCtD
Methimazole—Drowsiness—Efavirenz—acquired immunodeficiency syndrome	0.000657	0.00439	CcSEcCtD
Methimazole—Neuropathy peripheral—Efavirenz—acquired immunodeficiency syndrome	0.000644	0.0043	CcSEcCtD
Methimazole—Jaundice—Efavirenz—acquired immunodeficiency syndrome	0.00064	0.00427	CcSEcCtD
Methimazole—CYP2A6—lung—acquired immunodeficiency syndrome	0.000635	0.0269	CbGeAlD
Methimazole—Musculoskeletal discomfort—Amprenavir—acquired immunodeficiency syndrome	0.000631	0.00422	CcSEcCtD
Methimazole—Hepatitis—Indinavir—acquired immunodeficiency syndrome	0.000624	0.00417	CcSEcCtD
Methimazole—Paraesthesia—Amprenavir—acquired immunodeficiency syndrome	0.000622	0.00415	CcSEcCtD
Methimazole—Thrombocytopenia—Didanosine—acquired immunodeficiency syndrome	0.000619	0.00413	CcSEcCtD
Methimazole—Neuropathy peripheral—Delavirdine—acquired immunodeficiency syndrome	0.000616	0.00411	CcSEcCtD
Methimazole—Jaundice—Delavirdine—acquired immunodeficiency syndrome	0.000613	0.00409	CcSEcCtD
Methimazole—Leukopenia—Nelfinavir—acquired immunodeficiency syndrome	0.000603	0.00403	CcSEcCtD
Methimazole—Leukopenia—Stavudine—acquired immunodeficiency syndrome	0.000602	0.00402	CcSEcCtD
Methimazole—Vertigo—Abacavir—acquired immunodeficiency syndrome	0.000595	0.00397	CcSEcCtD
Methimazole—Leukopenia—Abacavir—acquired immunodeficiency syndrome	0.000593	0.00396	CcSEcCtD
Methimazole—Myalgia—Nevirapine—acquired immunodeficiency syndrome	0.000593	0.00396	CcSEcCtD
Methimazole—Arthralgia—Nevirapine—acquired immunodeficiency syndrome	0.000593	0.00396	CcSEcCtD
Methimazole—Hepatitis—Efavirenz—acquired immunodeficiency syndrome	0.00059	0.00394	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Didanosine—acquired immunodeficiency syndrome	0.000576	0.00384	CcSEcCtD
Methimazole—Myalgia—Nelfinavir—acquired immunodeficiency syndrome	0.000574	0.00383	CcSEcCtD
Methimazole—Arthralgia—Nelfinavir—acquired immunodeficiency syndrome	0.000574	0.00383	CcSEcCtD
Methimazole—Arthralgia—Stavudine—acquired immunodeficiency syndrome	0.000572	0.00382	CcSEcCtD
Methimazole—Myalgia—Stavudine—acquired immunodeficiency syndrome	0.000572	0.00382	CcSEcCtD
Methimazole—Neuropathy peripheral—Ritonavir—acquired immunodeficiency syndrome	0.00057	0.0038	CcSEcCtD
Methimazole—Oedema—Nevirapine—acquired immunodeficiency syndrome	0.000568	0.00379	CcSEcCtD
Methimazole—Paraesthesia—Didanosine—acquired immunodeficiency syndrome	0.000567	0.00379	CcSEcCtD
Methimazole—Jaundice—Ritonavir—acquired immunodeficiency syndrome	0.000566	0.00378	CcSEcCtD
Methimazole—Hepatitis—Delavirdine—acquired immunodeficiency syndrome	0.000564	0.00377	CcSEcCtD
Methimazole—Arthralgia—Abacavir—acquired immunodeficiency syndrome	0.000564	0.00376	CcSEcCtD
Methimazole—Myalgia—Abacavir—acquired immunodeficiency syndrome	0.000564	0.00376	CcSEcCtD
Methimazole—Thrombocytopenia—Nevirapine—acquired immunodeficiency syndrome	0.000556	0.00371	CcSEcCtD
Methimazole—Dyspepsia—Didanosine—acquired immunodeficiency syndrome	0.000556	0.00371	CcSEcCtD
Methimazole—Alopecia—Indinavir—acquired immunodeficiency syndrome	0.000551	0.00368	CcSEcCtD
Methimazole—Oedema—Nelfinavir—acquired immunodeficiency syndrome	0.00055	0.00367	CcSEcCtD
Methimazole—Neuropathy peripheral—Saquinavir—acquired immunodeficiency syndrome	0.000548	0.00366	CcSEcCtD
Methimazole—Jaundice—Saquinavir—acquired immunodeficiency syndrome	0.000545	0.00364	CcSEcCtD
Methimazole—Oedema—Abacavir—acquired immunodeficiency syndrome	0.00054	0.00361	CcSEcCtD
Methimazole—Thrombocytopenia—Nelfinavir—acquired immunodeficiency syndrome	0.000539	0.0036	CcSEcCtD
Methimazole—Thrombocytopenia—Stavudine—acquired immunodeficiency syndrome	0.000537	0.00359	CcSEcCtD
Methimazole—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.000529	0.00353	CcSEcCtD
Methimazole—Vertigo—Zidovudine—acquired immunodeficiency syndrome	0.000525	0.0035	CcSEcCtD
Methimazole—Neuropathy peripheral—Lamivudine—acquired immunodeficiency syndrome	0.000523	0.00349	CcSEcCtD
Methimazole—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.000523	0.00349	CcSEcCtD
Methimazole—Hepatitis—Ritonavir—acquired immunodeficiency syndrome	0.000522	0.00348	CcSEcCtD
Methimazole—Alopecia—Efavirenz—acquired immunodeficiency syndrome	0.000521	0.00348	CcSEcCtD
Methimazole—Jaundice—Lamivudine—acquired immunodeficiency syndrome	0.00052	0.00347	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Nevirapine—acquired immunodeficiency syndrome	0.000518	0.00346	CcSEcCtD
Methimazole—Paraesthesia—Nevirapine—acquired immunodeficiency syndrome	0.00051	0.00341	CcSEcCtD
Methimazole—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.000505	0.00337	CcSEcCtD
Methimazole—Hepatitis—Saquinavir—acquired immunodeficiency syndrome	0.000502	0.00335	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.000501	0.00335	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Stavudine—acquired immunodeficiency syndrome	0.0005	0.00334	CcSEcCtD
Methimazole—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.000499	0.00333	CcSEcCtD
Methimazole—Alopecia—Delavirdine—acquired immunodeficiency syndrome	0.000499	0.00333	CcSEcCtD
Methimazole—Agranulocytosis—Lamivudine—acquired immunodeficiency syndrome	0.000498	0.00332	CcSEcCtD
Methimazole—Myalgia—Zidovudine—acquired immunodeficiency syndrome	0.000497	0.00332	CcSEcCtD
Methimazole—Arthralgia—Zidovudine—acquired immunodeficiency syndrome	0.000497	0.00332	CcSEcCtD
Methimazole—Paraesthesia—Nelfinavir—acquired immunodeficiency syndrome	0.000494	0.0033	CcSEcCtD
Methimazole—Paraesthesia—Stavudine—acquired immunodeficiency syndrome	0.000493	0.00329	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.000492	0.00329	CcSEcCtD
Methimazole—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00049	0.00327	CcSEcCtD
Methimazole—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.000489	0.00327	CcSEcCtD
Methimazole—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000489	0.0207	CbGeAlD
Methimazole—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.000488	0.00326	CcSEcCtD
Methimazole—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.000488	0.00326	CcSEcCtD
Methimazole—Paraesthesia—Abacavir—acquired immunodeficiency syndrome	0.000485	0.00324	CcSEcCtD
Methimazole—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.000484	0.00323	CcSEcCtD
Methimazole—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.000483	0.00322	CcSEcCtD
Methimazole—Hepatitis—Lamivudine—acquired immunodeficiency syndrome	0.000479	0.0032	CcSEcCtD
Methimazole—CYP2B6—skin of body—acquired immunodeficiency syndrome	0.000478	0.0203	CbGeAlD
Methimazole—Oedema—Zidovudine—acquired immunodeficiency syndrome	0.000477	0.00318	CcSEcCtD
Methimazole—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.000467	0.00312	CcSEcCtD
Methimazole—CYP2C19—blood—acquired immunodeficiency syndrome	0.000466	0.0197	CbGeAlD
Methimazole—Myalgia—Indinavir—acquired immunodeficiency syndrome	0.000463	0.00309	CcSEcCtD
Methimazole—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.000463	0.00309	CcSEcCtD
Methimazole—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.000461	0.00308	CcSEcCtD
Methimazole—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000451	0.00301	CcSEcCtD
Methimazole—CYP2A6—brain—acquired immunodeficiency syndrome	0.000449	0.019	CbGeAlD
Methimazole—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000449	0.003	CcSEcCtD
Methimazole—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000447	0.00298	CcSEcCtD
Methimazole—Alopecia—Saquinavir—acquired immunodeficiency syndrome	0.000444	0.00296	CcSEcCtD
Methimazole—Oedema—Indinavir—acquired immunodeficiency syndrome	0.000443	0.00296	CcSEcCtD
Methimazole—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.000441	0.00295	CcSEcCtD
Methimazole—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000441	0.00294	CcSEcCtD
Methimazole—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.00044	0.00294	CcSEcCtD
Methimazole—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000437	0.00292	CcSEcCtD
Methimazole—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.000437	0.00292	CcSEcCtD
Methimazole—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.000437	0.00292	CcSEcCtD
Methimazole—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000437	0.00292	CcSEcCtD
Methimazole—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000437	0.00291	CcSEcCtD
Methimazole—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000436	0.00291	CcSEcCtD
Methimazole—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000435	0.0029	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000434	0.0029	CcSEcCtD
Methimazole—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000434	0.0029	CcSEcCtD
Methimazole—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000434	0.0029	CcSEcCtD
Methimazole—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000434	0.00289	CcSEcCtD
Methimazole—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000432	0.0183	CbGeAlD
Methimazole—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000429	0.00287	CcSEcCtD
Methimazole—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000428	0.00286	CcSEcCtD
Methimazole—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000427	0.00285	CcSEcCtD
Methimazole—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000424	0.00283	CcSEcCtD
Methimazole—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.000423	0.00283	CcSEcCtD
Methimazole—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.00042	0.0028	CcSEcCtD
Methimazole—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000418	0.00279	CcSEcCtD
Methimazole—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000418	0.00279	CcSEcCtD
Methimazole—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000412	0.00275	CcSEcCtD
Methimazole—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.00041	0.00274	CcSEcCtD
Methimazole—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000408	0.00272	CcSEcCtD
Methimazole—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000407	0.00271	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000404	0.0027	CcSEcCtD
Methimazole—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000402	0.00268	CcSEcCtD
Methimazole—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000402	0.00268	CcSEcCtD
Methimazole—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000401	0.00268	CcSEcCtD
Methimazole—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000399	0.0169	CbGeAlD
Methimazole—Rash—Didanosine—acquired immunodeficiency syndrome	0.000398	0.00266	CcSEcCtD
Methimazole—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000398	0.00266	CcSEcCtD
Methimazole—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000398	0.00266	CcSEcCtD
Methimazole—Headache—Didanosine—acquired immunodeficiency syndrome	0.000396	0.00264	CcSEcCtD
Methimazole—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000394	0.00263	CcSEcCtD
Methimazole—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000393	0.00262	CcSEcCtD
Methimazole—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000392	0.00262	CcSEcCtD
Methimazole—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000391	0.00261	CcSEcCtD
Methimazole—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.00039	0.00261	CcSEcCtD
Methimazole—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000389	0.0026	CcSEcCtD
Methimazole—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000388	0.00259	CcSEcCtD
Methimazole—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	0.000387	0.0164	CbGeAlD
Methimazole—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000387	0.00258	CcSEcCtD
Methimazole—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000387	0.00258	CcSEcCtD
Methimazole—CYP2B6—digestive system—acquired immunodeficiency syndrome	0.000383	0.0162	CbGeAlD
Methimazole—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000382	0.00255	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000382	0.00255	CcSEcCtD
Methimazole—CYP1A2—blood—acquired immunodeficiency syndrome	0.00038	0.0161	CbGeAlD
Methimazole—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000379	0.0161	CbGeAlD
Methimazole—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000379	0.00253	CcSEcCtD
Methimazole—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000377	0.00252	CcSEcCtD
Methimazole—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000376	0.00251	CcSEcCtD
Methimazole—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000375	0.00251	CcSEcCtD
Methimazole—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000375	0.0025	CcSEcCtD
Methimazole—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000373	0.00249	CcSEcCtD
Methimazole—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000372	0.00249	CcSEcCtD
Methimazole—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000372	0.00248	CcSEcCtD
Methimazole—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000372	0.00248	CcSEcCtD
Methimazole—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000371	0.00247	CcSEcCtD
Methimazole—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000369	0.00246	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000365	0.00244	CcSEcCtD
Methimazole—CYP2B6—blood—acquired immunodeficiency syndrome	0.000365	0.0154	CbGeAlD
Methimazole—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.000363	0.0154	CbGeAlD
Methimazole—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000363	0.00242	CcSEcCtD
Methimazole—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000361	0.00241	CcSEcCtD
Methimazole—CYP2C9—blood—acquired immunodeficiency syndrome	0.000361	0.0153	CbGeAlD
Methimazole—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.00036	0.0024	CcSEcCtD
Methimazole—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.000359	0.0152	CbGeAlD
Methimazole—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000358	0.00239	CcSEcCtD
Methimazole—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000358	0.00239	CcSEcCtD
Methimazole—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000357	0.00238	CcSEcCtD
Methimazole—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000356	0.00238	CcSEcCtD
Methimazole—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000356	0.00238	CcSEcCtD
Methimazole—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000355	0.00237	CcSEcCtD
Methimazole—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000355	0.00237	CcSEcCtD
Methimazole—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000353	0.00236	CcSEcCtD
Methimazole—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000352	0.00235	CcSEcCtD
Methimazole—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00035	0.00234	CcSEcCtD
Methimazole—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00035	0.00234	CcSEcCtD
Methimazole—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000349	0.00233	CcSEcCtD
Methimazole—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000349	0.00233	CcSEcCtD
Methimazole—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000347	0.00232	CcSEcCtD
Methimazole—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000347	0.00231	CcSEcCtD
Methimazole—Rash—Stavudine—acquired immunodeficiency syndrome	0.000346	0.00231	CcSEcCtD
Methimazole—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000346	0.00231	CcSEcCtD
Methimazole—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000345	0.0023	CcSEcCtD
Methimazole—Headache—Stavudine—acquired immunodeficiency syndrome	0.000344	0.00229	CcSEcCtD
Methimazole—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000344	0.00229	CcSEcCtD
Methimazole—CYP2E1—blood—acquired immunodeficiency syndrome	0.000342	0.0145	CbGeAlD
Methimazole—Rash—Abacavir—acquired immunodeficiency syndrome	0.000341	0.00227	CcSEcCtD
Methimazole—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00034	0.00227	CcSEcCtD
Methimazole—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.00034	0.00227	CcSEcCtD
Methimazole—Headache—Abacavir—acquired immunodeficiency syndrome	0.000339	0.00226	CcSEcCtD
Methimazole—CYP2B6—vagina—acquired immunodeficiency syndrome	0.000338	0.0143	CbGeAlD
Methimazole—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000338	0.00225	CcSEcCtD
Methimazole—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000337	0.00225	CcSEcCtD
Methimazole—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000337	0.00225	CcSEcCtD
Methimazole—CYP1A2—lung—acquired immunodeficiency syndrome	0.000333	0.0141	CbGeAlD
Methimazole—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000333	0.00222	CcSEcCtD
Methimazole—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000333	0.00222	CcSEcCtD
Methimazole—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000333	0.00222	CcSEcCtD
Methimazole—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000331	0.00221	CcSEcCtD
Methimazole—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.00033	0.014	CbGeAlD
Methimazole—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.00033	0.0022	CcSEcCtD
Methimazole—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000327	0.00218	CcSEcCtD
Methimazole—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000326	0.00218	CcSEcCtD
Methimazole—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000326	0.00218	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000325	0.00217	CcSEcCtD
Methimazole—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000321	0.00214	CcSEcCtD
Methimazole—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.00032	0.00214	CcSEcCtD
Methimazole—CYP2B6—lung—acquired immunodeficiency syndrome	0.00032	0.0135	CbGeAlD
Methimazole—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000318	0.00213	CcSEcCtD
Methimazole—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000317	0.00212	CcSEcCtD
Methimazole—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000317	0.00212	CcSEcCtD
Methimazole—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000314	0.0021	CcSEcCtD
Methimazole—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000314	0.00209	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00031	0.00207	CcSEcCtD
Methimazole—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000306	0.00204	CcSEcCtD
Methimazole—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000303	0.00202	CcSEcCtD
Methimazole—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000303	0.00202	CcSEcCtD
Methimazole—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000301	0.00201	CcSEcCtD
Methimazole—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.0003	0.00201	CcSEcCtD
Methimazole—CYP2E1—lung—acquired immunodeficiency syndrome	0.0003	0.0127	CbGeAlD
Methimazole—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.0003	0.002	CcSEcCtD
Methimazole—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000299	0.00199	CcSEcCtD
Methimazole—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000296	0.00198	CcSEcCtD
Methimazole—CYP2B6—nervous system—acquired immunodeficiency syndrome	0.000296	0.0125	CbGeAlD
Methimazole—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000294	0.00197	CcSEcCtD
Methimazole—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000293	0.00196	CcSEcCtD
Methimazole—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000289	0.0122	CbGeAlD
Methimazole—CYP2B6—central nervous system—acquired immunodeficiency syndrome	0.000285	0.0121	CbGeAlD
Methimazole—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000284	0.012	CbGeAlD
Methimazole—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000284	0.00189	CcSEcCtD
Methimazole—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000283	0.00189	CcSEcCtD
Methimazole—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000283	0.00189	CcSEcCtD
Methimazole—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000282	0.00188	CcSEcCtD
Methimazole—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000282	0.00188	CcSEcCtD
Methimazole—Rash—Indinavir—acquired immunodeficiency syndrome	0.00028	0.00187	CcSEcCtD
Methimazole—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000279	0.00186	CcSEcCtD
Methimazole—Headache—Indinavir—acquired immunodeficiency syndrome	0.000278	0.00185	CcSEcCtD
Methimazole—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000278	0.0118	CbGeAlD
Methimazole—CYP3A4—blood—acquired immunodeficiency syndrome	0.000275	0.0117	CbGeAlD
Methimazole—CYP2D6—blood—acquired immunodeficiency syndrome	0.000271	0.0115	CbGeAlD
Methimazole—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00027	0.00181	CcSEcCtD
Methimazole—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000269	0.0018	CcSEcCtD
Methimazole—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.000267	0.0113	CbGeAlD
Methimazole—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000266	0.00178	CcSEcCtD
Methimazole—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000264	0.00176	CcSEcCtD
Methimazole—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000264	0.00176	CcSEcCtD
Methimazole—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000263	0.00176	CcSEcCtD
Methimazole—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000262	0.00175	CcSEcCtD
Methimazole—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000262	0.00175	CcSEcCtD
Methimazole—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000255	0.0017	CcSEcCtD
Methimazole—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000253	0.00169	CcSEcCtD
Methimazole—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000252	0.00169	CcSEcCtD
Methimazole—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000252	0.00169	CcSEcCtD
Methimazole—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000251	0.00168	CcSEcCtD
Methimazole—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000249	0.00166	CcSEcCtD
Methimazole—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000241	0.00161	CcSEcCtD
Methimazole—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000238	0.00159	CcSEcCtD
Methimazole—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000236	0.00157	CcSEcCtD
Methimazole—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000234	0.00156	CcSEcCtD
Methimazole—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000233	0.00156	CcSEcCtD
Methimazole—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000232	0.00155	CcSEcCtD
Methimazole—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000227	0.00151	CcSEcCtD
Methimazole—CYP2B6—brain—acquired immunodeficiency syndrome	0.000226	0.00958	CbGeAlD
Methimazole—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000225	0.0015	CcSEcCtD
Methimazole—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000225	0.0015	CcSEcCtD
Methimazole—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000223	0.00149	CcSEcCtD
Methimazole—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000223	0.00947	CbGeAlD
Methimazole—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00022	0.00147	CcSEcCtD
Methimazole—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.00022	0.00932	CbGeAlD
Methimazole—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000216	0.00144	CcSEcCtD
Methimazole—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000215	0.00912	CbGeAlD
Methimazole—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000215	0.00143	CcSEcCtD
Methimazole—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000214	0.00143	CcSEcCtD
Methimazole—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000213	0.00142	CcSEcCtD
Methimazole—CYP2E1—brain—acquired immunodeficiency syndrome	0.000212	0.00899	CbGeAlD
Methimazole—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000212	0.00141	CcSEcCtD
Methimazole—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000212	0.00897	CbGeAlD
Methimazole—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000202	0.00135	CcSEcCtD
Methimazole—CYP2D6—brain—acquired immunodeficiency syndrome	0.000168	0.00712	CbGeAlD
